You just read:

Initiation Of Clinical Trial Collaboration Evaluating Halozyme's PEGPH20 In Combination With Anti-PDL1 Immunotherapy

News provided by

Halozyme Therapeutics, Inc.

Jul 13, 2017, 08:30 ET